Sandra R. Wolman

6.0k citations

103 papers · 4.8k indexed · 1 hit paper · h-index 32

Co-authors: Arleen D. Auerbach Herbert D. Soule Terry Maloney Robert J. Pauley Charles M. McGrath José Russo Richard F. Jones S.C. Brooks
Topics: Cancer Genomics and Diagnostics (21 papers)Genomic variations and chromosomal abnormalities (15 papers)Cancer-related Molecular Pathways (11 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Nature Science Blood
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Sandra R. Wolman

102 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

1990 1.3k citations Herbert D. Soule, Terry Maloney et al. PubMed profile →

Peers

Countries citing papers authored by Sandra R. Wolman

Since Specialization

Citations

This map shows the geographic impact of Sandra R. Wolman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra R. Wolman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra R. Wolman more than expected).

Fields of papers citing papers by Sandra R. Wolman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra R. Wolman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra R. Wolman. The network helps show where Sandra R. Wolman may publish in the future.

Co-authorship network of co-authors of Sandra R. Wolman

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra R. Wolman. A scholar is included among the top collaborators of Sandra R. Wolman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra R. Wolman. Sandra R. Wolman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk factors for breast cancer from benign breast disease in a diverse population 2008 ·Breast Cancer Research and Treatment ·Maria J. Worsham,Usha Raju,Mei Lü,Alissa Kapke,(unknown),Jingfang Cheng,Varsha Shah,Adnan T. Savera,Sandra R. Wolman	42
2	Risk factors for breast cancer from benign breast disease in a diverse population 2007 ·Cancer Epidemiology and Prevention Biomarkers ·(unknown),Usha Raju,Mei Lü,Alissa Kapke,Sandra R. Wolman,Maria J. Worsham	1
3	Benign breast disease heterogeneity: association with histopathology, age, and ethnicity 2007 ·Breast Cancer Research and Treatment ·Jingfang Cheng,Shijing Qiu,Usha Raju,Sandra R. Wolman,Maria J. Worsham	16
4	Establishing a molecular continuum in breast cancer DNA microarrays and benign breast disease 2001 ·Cytometry ·Maria J. Worsham,Gerard Pals,Usha Raju,Sandra R. Wolman	8
5	Chromosomal markers: Signposts on the road to understanding neoplastic disease 1998 ·Diagnostic Cytopathology ·Sandra R. Wolman	1
6	Applications of fluorescence in situ hybridization techniques in cytopathology 1997 ·Cancer ·Sandra R. Wolman	16
7	INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes 1996 ·Breast Cancer Research and Treatment ·Robert J. Pauley,Phyllis A. Gimotty,(unknown),Peter J. Dawson,Sandra R. Wolman	13
8	Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotypes and fluorescence in situ hybridization 1995 ·Human Pathology ·Maria J. Worsham,Sandra R. Wolman,Thomas E. Carey,Richard J. Zarbo,Michael S. Benninger,Daniel L. Van Dyke	82
9	Chromosomal markers of immortalization in human breast epithelium 1994 ·Genes Chromosomes and Cancer ·Sandra R. Wolman,Anwar N. Mohamed,Gloria H. Heppner,Herbert D. Soule	13
10	Complementarity of interphase and metaphase chromosome analysis in human renal tumors 1993 ·Genes Chromosomes and Cancer ·Sandra R. Wolman,Frederic M. Waldman,Margit Balázs	26
11	The chromosomes in human cancer. 1992 ·The American Journal of Human Genetics ·Sandra R. Wolman	9
12	A retrospective analysis of breast cancer based on outcome differences 1991 ·Human Pathology ·Sandra R. Wolman,Helen Feiner,Roger Schinella,Phyllis A. Gimotty,Helen E. Ownby,Terry Maloney,Peter J. Dawson	12
13	Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.breakdown → 1990 ·PubMed ·Herbert D. Soule,Terry Maloney,Sandra R. Wolman,William Peterson,(unknown),Charles M. McGrath,José Russo,Robert J. Pauley,Richard F. Jones,S.C. Brooks	1258
14	A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma 1990 ·Cancer ·Mark M. Zalupski,John F. Ensley,James R. Ryan,Suzanne M. Selvaggi,Laurence H. Baker,Sandra R. Wolman	32
15	Dermatoglyphic Study in Autistic Children and Controls 1990 ·Journal of the American Academy of Child & Adolescent Psychiatry ·Sandra R. Wolman,Magda Campbell,(unknown),Stephen I. Deutsch,(unknown)	4
16	Chromosomal aberrations as markers of oncogene amplification 1989 ·Human Pathology ·Sandra R. Wolman,A.S. Henderson	9
17	Charlotte Friend, Ph.D. 1921‐1987 A Scientist's Life 1989 ·Annals of the New York Academy of Sciences ·Leila Diamond,Sandra R. Wolman	1
18	Development and progression of karyotypic variability in melanoma K1735 following X-irradiation. 1985 ·PubMed ·Sandra R. Wolman,Lydia E. McMorrow,Isaiah J. Fidler,James E. Talmadge	14
19	Sister-chromatid exchanges in association with occupational exposure to ethylene oxide 1984 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·Paul D. Stolley,Keith A. Soper,Sheila M. Galloway,(unknown),Sandra A. Norman,Sandra R. Wolman	66
20	Fanconi's anemia with growth hormone deficiency 1971 ·The Journal of Pediatrics ·Carl Pochedly,P.J. Collipp,Sandra R. Wolman,(unknown),Iraj Rezvani	27

About Sandra R. Wolman

Sandra R. Wolman is a scholar working on Cancer Research, Pathology and Forensic Medicine and Hematology, having authored 103 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (21 papers), Genomic variations and chromosomal abnormalities (15 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (1.5k citations) and Molecular Biology (2.5k citations). Sandra R. Wolman has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Arleen D. Auerbach, Herbert D. Soule, Terry Maloney, Robert J. Pauley, Charles M. McGrath, José Russo, Richard F. Jones, S.C. Brooks, William Peterson and James E. Talmadge. Their work appears in journals such as Nature, Science and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact